Apafant | Interleukin Related interleukin-related.com

Product Name :
Apafant

Search keywords :
Apafant

drugId :
null

Target Vo:
Platelet activating factor receptor

Target Vo Short Name :
PAFR

Moa_Name:
Platelet activating factor receptor antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Boehringer Ingelheim Gmbh

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Rhinitis, Allergic

Termination Status :
Phase 3 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Bmi1 Antibody
Phospho-mTOR (Ser2481) Antibody
RSK1 p90 Antibody (YA676): RSK1 p90 Antibody (YA676) is a non-conjugated and Mouse origined monoclonal antibody about 83 kDa, targeting to RSK1 p90 (6B9). It can be used for WB,IP assays with tag free, in the background of Human, Mouse, Monkey.

Author: Interleukin Related

Related Posts